Twigg Geoffrey, David Tosin, Taylor Joshua
Apple Discount Drugs, Salisbury, MD 21804, USA.
School of Pharmacy, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA.
Pharmacy (Basel). 2019 Jun 17;7(2):66. doi: 10.3390/pharmacy7020066.
For years many pharmacists have been performing 'brown bag' medication reviews for patients. While most pharmacists and student pharmacists are familiar with this process, it is important to determine the value patients receive from this service. Over the course of this study the authors attempted to modernize the medication reconciliation process and collect data on patient prescription drug and over-the-counter drug use, along with quantifying the types of interventions the pharmacy's clinical staff performed for patients during this process. The pharmacy partnered with a Quality Improvement Organization to trial their Blue Bag Intervention (BBI) program. The BBI program offered several additional services to the traditional brown bag review. The BBI was instituted as a follow-up tool in the pharmacy's diabetes self-management education/training clinic to aid in patient follow-up and help the clinical staff identify medication-related events such as medication adherence issues and drug-drug interactions. The clinical staff identified approximately 2.2 events per patient with over 50% being issues that affected patient safety.
多年来,许多药剂师一直在为患者进行“棕色纸袋”药物审查。虽然大多数药剂师和药剂学学生都熟悉这个过程,但确定患者从这项服务中获得的价值很重要。在这项研究过程中,作者试图使药物调和过程现代化,并收集患者处方药和非处方药使用的数据,同时量化药房临床工作人员在此过程中为患者进行的干预类型。该药房与一个质量改进组织合作,试行其“蓝色纸袋干预”(BBI)计划。BBI计划在传统的棕色纸袋审查基础上提供了几项额外服务。BBI被用作该药房糖尿病自我管理教育/培训诊所的后续工具,以协助患者随访,并帮助临床工作人员识别与药物相关的事件,如用药依从性问题和药物相互作用。临床工作人员为每位患者识别出约2.2个事件,其中超过50%是影响患者安全的问题。